52 results on '"Kang, Hye-Ryun"'
Search Results
2. Petasites japonicus Stimulates the Proliferation of Mouse Spermatogonial Stem Cells.
- Author
-
Kang, Hye-Ryun, Lee, Yong-An, Kim, Yong-Hee, Lee, Dong Gu, Kim, Bang-Jin, Kim, Ki-Jung, Kim, Byung-Gak, Oh, Myeong-Geun, Han, Chan Kyu, Lee, Sanghyun, and Ryu, Buom-Yong
- Subjects
- *
SPERMATOGENESIS , *PETASITES , *STEM cells , *CELL proliferation , *HERBAL medicine , *GERM cells , *TRANSPLANTATION of organs, tissues, etc. - Abstract
Oriental natural plants have been used as medical herbs for the treatment of various diseases for over 2,000 years. In this study, we evaluated the effect of several natural plants on the preservation of male fertility by assessing the ability of plant extracts to stimulate spermatogonial stem cell (SSC) proliferation by using a serum-free culture method. In vitro assays showed that Petasites japonicus extracts, especially the butanol fraction, have a significant effect on germ cells proliferation including SSCs. The activity of SSCs cultured in the presence of the Petasites japonicus butanol fraction was confirmed by normal colony formation and spermatogenesis following germ cell transplantation of the treated SSCs. Our findings could lead to the discovery of novel factors that activate SSCs and could be useful for the development of technologies for the prevention of male infertility. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
3. The Incidence and Risk Factors of Infusion-Related Reactions to Rituximab for Treating B Cell Malignancies in a Single Tertiary Hospital.
- Author
-
Jung, Jae-Woo, Kang, Hye-Ryun, Lee, Se-Hoon, and Cho, Sang-Heon
- Subjects
- *
ACADEMIC medical centers , *B cells , *CHI-squared test , *CHRONIC lymphocytic leukemia , *CONFIDENCE intervals , *EPIDEMIOLOGY , *INTRAVENOUS therapy , *LYMPHOMAS , *MEDICAL records , *RESEARCH funding , *RITUXIMAB , *DATA analysis , *RETROSPECTIVE studies , *DATA analysis software , *DESCRIPTIVE statistics - Abstract
Background: Rituximab is a chimeric anti-CD20 human/mouse monoclonal antibody. As its usage has increased, there have been growing concerns about rituximab-related infusion-related reactions (IRRs). Objective: The aim of this study is to verify the clinical features and risk factors of IRRs by rituximab, and to help establish clinical guidelines for their prevention. Methods: We reviewed electronic medical records of all the adult patients who were prescribed rituximab from January 2005 to July 2010 for B cell malignancy at Seoul National University Hospital. Results: A total of 389 cases of IRRs by rituximab (12.5% of a total of 3,104 infusions) were identified in 281 patients (49.4% of a total of 568 patients). IRRs most frequently occurred during the first infusion (40.5%) and abruptly decreased in subsequent infusions to rates of 3-8% (p < 0.001). The incidence of IRRs in patients premedicated with corticosteroid for their first infusion was significantly lower when compared to patients not pretreated with corticosteroid prior to rituximab infusion (8.3 vs. 41.2%, p = 0.017). Conclusion: Almost half of all patients in the study experienced IRRs at least once during their scheduled rituximab treatment. Premedication with corticosteroid can be recommended in patients with high risk of IRR in the first infusion. © 2014 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
4. Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposure.
- Author
-
Lee, Suh-Young, Kang, Hye-Ryun, Song, Woo-Jung, Lee, Kyung-Hun, Han, Sae-Won, and Cho, Sang
- Subjects
- *
GASTROINTESTINAL cancer treatment , *OXALIPLATIN , *ALLERGIES , *PREMEDICATION , *GASTROINTESTINAL cancer , *CANCER chemotherapy , *DRUG administration , *PATIENTS , *THERAPEUTICS - Abstract
Purpose: This study investigated the characteristics of oxaliplatin-related hypersensitivity reactions (HSR) and evaluated the efficacy of premedication and desensitization administration for controlling HSR in patients with gastrointestinal malignancy. Methods: This retrospective study includes oxaliplatin hypersensitivity cases reported to our in-hospital, adverse drug reaction monitoring system between May 2008 and April 2012. We analyzed administration histories of oxaliplatin and premedication treatments, chemotherapy cycle and severity of the initial HSR, and prophylactic measures and their outcomes in subsequent chemotherapy cycles. Results: One hundred and seventy-three patients showed hypersensitivity to oxaliplatin-based chemotherapy. Oxaliplatin HSR developed after mean chemotherapy cycle 6.3 ± 0.3. Specifically, while HSR occurred at cycle 7.6 ± 0.3 in the case of patients previously unexposed to oxaliplatin-containing chemotherapy, it occurred at cycle 2.6 ± 0.3 in previously exposed patients. Of the 173 patients who exhibited HSR, premedication was administered in 134 patients and 71.6 % of them succeeded in preventing HSR. Desensitization was attempted in 38 patients, including 20 patients in whom premedication administration was unsuccessful, and 89 % of desensitized patients successfully underwent oxaliplatin chemotherapy without HSR. As severity of HSR increased, the success rate by premedication decreased and the percentage of patients that underwent desensitization increased. Conclusions: Attention should be paid to patients with any prior exposure to oxaliplatin, especially during early chemotherapy cycles. Given the high success rate of preventing HSR by desensitization administration and its apparent safety profile, we suggest that desensitization be considered as the first option for the treatment of grades 3 and 4 HSR cases. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
5. Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans.
- Author
-
Kang, Hye-Ryun, Jee, Young Koo, Kim, Yon-Soo, Lee, Chang Hwa, Jung, Jae-Woo, Kim, Sae Hoon, Park, Heung-Woo, Chang, Yoon-Seok, Jang, In-Jin, Cho, Sang-Heon, Min, Kyung-Up, Kim, Sang-Heon, and Lee, Kyung Wha
- Abstract
Recent investigations suggest genetic susceptibility of allopurinol-induced severe cutaneous adverse reactions (SCARs). However, the strength of association was variable according to phenotypes and ethnic backgrounds. To explore genetic markers for allopurinol-induced SCARs in Koreans, we genotyped human leukocyte antigen (HLA) class I alleles of 25 cases of allopurinol-induced SCARs (20 cases of drug-induced hypersensitivity syndrome and five cases of Stevens-Johnson syndrome/toxic epidermal necrolysis) and 57 patients tolerant to allopurinol. Frequencies of B∗5801 [92.0 vs. 10.5%, Pc=2.45×10-11, odds ratio (OR)=97.8], Cw∗0302 (92.0 vs. 12.3%, Pc=9.39×10-11, OR=82.1), and A∗3303 (88.0 vs. 26.3%, Pc=3.31×10-6, OR=20.5) were significantly higher in SCARs compared with tolerant controls. In contrast, A∗0201 was not found in SCARs patients despite relatively high frequency in tolerant controls (29.8%). We found strong positive association of HLA-B∗5801 and negative association of HLA-A∗0201 with the development of allopurinol-induced SCARs in the Korean population. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
6. Different inflammatory features of asthma according to gut microbiome enterotype.
- Author
-
Sohn, Kyoung‐Hee, Choi, Sungmi, Jung, Jae‐Woo, Choi, Jeong‐Hee, Cho, Sang‐Heon, Yi, Hana, and Kang, Hye‐Ryun
- Subjects
- *
GUT microbiome , *ASTHMA , *VOCAL cord dysfunction - Abstract
This article explores the connection between the gut microbiome and asthma in adults. The study reveals that there is a diverse airway microbiome linked to the severity and exacerbation of asthma. However, the composition of the gut and induced sputum microbiomes did not exhibit significant differences based on the morbidity or severity of asthma. The study also identifies three distinct clusters of gut microbiome patterns, each associated with different inflammatory features of asthma. This research enhances our understanding of the gut-lung axis and the potential role of the gut microbiome in asthma. The findings suggest that further investigation into the impact of the gut microbiome on asthma phenotypes and endotypes could lead to new therapeutic approaches for asthma treatment. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
7. Disparities and inequalities of penicillin allergy in the Asia‐Pacific region.
- Author
-
Li, Philip H., Pawankar, Ruby, Thong, Bernard Y. H., Mak, Hugo W. F., Chan, Grace, Chung, Wen‐Hung, Juan, Meng, Kang, Hye‐Ryun, Kim, Byung‐Keun, Lobo, Rommel Crisenio M., Lucas, Michaela, Pham, Duy Le, Ranasinghe, Thushali, Rengganis, Iris, Rerkpattanapipat, Ticha, Sonomjamts, Munkhbayarlakh, Tsai, Yi‐Giien, Wang, Jiu‐Yao, Yamaguchi, Masao, and Yun, James
- Subjects
- *
PENICILLIN , *ALLERGIES , *MEDICAL personnel - Abstract
On average, how many individual consultations/visits on average are patients required to attend for entire penicillin allergy delabelling process (including history taking, allergy testing, provocation testing etc.)
a. If your centre performs penicillin skin prick/intradermal testing, which reagents do you routinely include in your penicillin allergy workup? The overwhelming burden of penicillin "allergy" labels remains a global public health concern associated with a myriad of adverse clinical outcomes.[1] The epidemiology and sensitization patterns of penicillin allergy varies greatly and remain largely unknown in the Asia-Pacific (AP) region.[[2], [4]] This international survey was performed to investigate the epidemiology, healthcare infrastructures and clinical practices pertaining to penicillin allergy in AP. In addition to penicillin allergy labels, what proportion (%) of patients have other drug allergy labels?. [Extracted from the article] - Published
- 2023
- Full Text
- View/download PDF
8. Correction: Petasites japonicus Stimulates the Proliferation of Mouse Spermatogonial Stem Cells.
- Author
-
Kang, Hye-Ryun, Lee, Yong-An, Kim, Yong-Hee, Lee, Dong Gu, Kim, Bang-Jin, Kim, Ki-Jung, Kim, Byung-Gak, Oh, Myeong-Geun, Han, Chan Kyu, Lee, Sanghyun, and Ryu, Buom-Yong
- Subjects
- *
PETASITES , *SPERMATOGENESIS , *STEM cells , *CELL proliferation , *MEDICAL research , *MEDICAL publishing - Published
- 2015
- Full Text
- View/download PDF
9. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis.
- Author
-
Choi, Sun Mi, Mo, Yosep, Bang, Ji-Young, Ko, Young Gyun, Ahn, Yoon Hae, Kim, Hye Young, Koh, Jaemoon, Yim, Jae-Joon, and Kang, Hye-Ryun
- Subjects
- *
PULMONARY fibrosis , *MESENCHYMAL stem cells , *INTRAVENOUS therapy , *IDIOPATHIC pulmonary fibrosis , *UMBILICAL cord , *LABORATORY mice - Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease that has no cure. Although mesenchymal stem cells (MSCs) have been reported to ameliorate lung inflammation and fibrosis in mouse models, their mechanisms of action remain unknown. Therefore, we aimed to determine the changes in various immune cells, especially macrophages and monocytes, involved in the effects of MSC treatment on pulmonary fibrosis. Methods: We collected and analyzed explanted lung tissues and blood from patients with IPF who underwent lung transplantation. After establishing a pulmonary fibrosis model via the intratracheal administration of bleomycin (BLM) to 8-week-old mice, MSCs derived from human umbilical cords were administered intravenously or intratracheally on day 10 and the lungs were immunologically analyzed on days 14 and 21. Flow cytometry was performed to analyze the immune cell characteristics, and gene expression levels were examined using quantitative reverse transcription-polymerase chain reaction. Results: In the histological analysis of explanted human lung tissues, the terminally fibrotic areas contained a larger number of macrophages and monocytes than the early fibrotic areas of the lungs. When human monocyte-derived macrophages (MoMs) were stimulated with interleukin-13 in vitro, the expression of type 2 macrophage (M2) markers was more prominent in MoMs from the classical monocyte subset than in those from intermediate or non-classical monocyte subsets, and MSCs suppressed M2 marker expression independent of MoM subsets. In the mouse model, the increased number of inflammatory cells in the bronchoalveolar lavage fluid and the degree of lung fibrosis observed in BLM-treated mice were significantly reduced by MSC treatment, which tended to be more prominent with intravenous administration than intratracheal administration. Both M1 and M2 MoMs were upregulated in BLM-treated mice. The M2c subset of M2 MoMs was significantly reduced by MSC treatment. Among M2 MoMs, M2 MoMs derived from Ly6C+ monocytes were most effectively regulated by the intravenous administration, not intratracheal administration, of MSCs. Conclusions: Inflammatory classical monocytes may play a role in lung fibrosis in human IPF and BLM-induced pulmonary fibrosis. Intravenous rather than intratracheal administration of MSCs may ameliorate pulmonary fibrosis by inhibiting monocyte differentiation into M2 macrophages. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. 153-P: HLA Association With Allopurinol-Induced Severe Cutaneous Adverse Reactions in Koreans
- Author
-
Lee, Kyung Wha, Kang, Hye-Ryun, Jee, Young Koo, Kim, Yon-Soo, Lee, Chang-Hwa, Park, Heung-Woo, Chang, Yoon-Seok, Cho, Sang-Heon, Min, Kyung-Up, and Kim, Sang-Heon
- Published
- 2010
- Full Text
- View/download PDF
11. Peripheral blood transcriptomic clusters uncovered immune phenotypes of asthma.
- Author
-
Lee, Hyun Woo, Baek, Min-gyung, Choi, Sungmi, Ahn, Yoon Hae, Bang, Ji-Young, Sohn, Kyoung-Hee, Kang, Min-Gyu, Jung, Jae-Woo, Choi, Jeong-Hee, Cho, Sang-Heon, Yi, Hana, and Kang, Hye-Ryun
- Subjects
- *
TRANSCRIPTOMES , *MONONUCLEAR leukocytes , *PHENOTYPES , *ASTHMA , *GENE ontology , *HIERARCHICAL clustering (Cluster analysis) , *MILK allergy - Abstract
Background: Transcriptomic analysis has been used to elucidate the complex pathogenesis of heterogeneous disease and may also contribute to identify potential therapeutic targets by delineating the hub genes. This study aimed to investigate whether blood transcriptomic clustering can distinguish clinical and immune phenotypes of asthmatics, and microbiome in asthmatics.Methods: Transcriptomic expression of peripheral blood mononuclear cells (PBMCs) from 47 asthmatics and 21 non-asthmatics was measured using RNA sequencing. A hierarchical clustering algorithm was used to classify asthmatics. Differentially expressed genes, clinical phenotypes, immune phenotypes, and microbiome of each transcriptomic cluster were assessed.Results: In asthmatics, three distinct transcriptomic clusters with numerously different transcriptomic expressions were identified. The proportion of severe asthmatics was highest in cluster 3 as 73.3%, followed by cluster 2 (45.5%) and cluster 1 (28.6%). While cluster 1 represented clinically non-severe T2 asthma, cluster 3 tended to include severe non-T2 asthma. Cluster 2 had features of both T2 and non-T2 asthmatics characterized by the highest serum IgE level and neutrophil-dominant sputum cell population. Compared to non-asthmatics, cluster 1 showed higher CCL23 and IL1RL1 expression while the expression of TREML4 was suppressed in cluster 3. CTSD and ALDH2 showed a significant positive linear relationship across three clusters in the order of cluster 1 to 3. No significant differences in the diversities of lung and gut microbiomes were observed among transcriptomic clusters of asthmatics and non-asthmatics. However, our study has limitations in that small sample size data were analyzed with unmeasured confounding factors and causal relationships or function pathways were not verified.Conclusions: Genetic clustering based on the blood transcriptome may provide novel immunological insight, which can be biomarkers of asthma immune phenotypes. Trial registration Retrospectively registered. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
12. HLA‐A*24:02 increase the risk of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms in HLA‐B*58:01 carriers in a Korean population; a multicenter cross‐sectional case‐control study.
- Author
-
Kim, Mi‐Yeong, Yun, James, Kang, Dong‐Yoon, Kim, Tae Hee, Oh, Min‐Kyung, Lee, Sunggun, Kang, Min‐Gyu, Nam, Young‐Hee, Choi, Jeong‐Hee, Yang, Min‐Suk, Han, Seung Seok, Lee, Hajeong, Cho, Hyun‐Jai, Yang, Jaeseok, Oh, Kook‐Hwan, Kim, Yon Su, Jung, Jae Woo, Lee, Kye Hwa, and Kang, Hye‐Ryun
- Subjects
- *
FISHER exact test , *CARRIERS , *KOREANS , *EOSINOPHILIA , *HISTOCOMPATIBILITY class I antigens , *CASE-control method , *CROSS-sectional method - Abstract
Background: HLA‐B*58:01 is a well‐known risk factor for allopurinol‐induced severe cutaneous adverse reactions (SCARs). However, only a minority of HLA‐B*58:01 carriers suffer SCARs after taking allopurinol. The aim of this study was to investigate subsidiary genetic markers that could identify those at further increased risk of developing allopurinol‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) in subjects with HLA‐B*58:01. Methods: Subjects with B*58:01 were enrolled (21 allopurinol‐induced DRESS and 52 allopurinol‐tolerant control). HLA‐A, ‐B, ‐C and ‐DRB1 alleles were compared. Comparison of risk between HLAs and allopurinol‐induced SCAR in separate populations was performed to support the results. Kruskal‐Wallis test, Pearson's chi‐square test, Fisher's exact test and binary logistic regression were used to analyze the risk of SCAR development. Results: Frequencies of A*24:02 (71.4 vs. 17.3%, p < 0.001, odds ratio [OR] = 12.0; 95% confidence interval [CI], 3.6–39.2) were significantly higher in B*58:01 (+) DRESS than B*58:01 (+) tolerant controls. In addition, DRB1*13:02 further increased the risk of DRESS. The phenotype frequency of A*24:02/DRB1*13:02 was significantly higher in the B*58:01 (+) DRESS group than in the B*58:01 (+) tolerant controls (52.4% vs. 5.8%, p < 0.001, OR, 66.0; 95% CI, 6.1–716.2). In 2782 allopurinol user cohort, the overall prevalence of DRESS was 0.22%, which increased to 1.62% and 2.86% in the presence of B*58:01 and B*58:01/A*24:02, respectively. Conclusion: The additional secondary screening with A*24:02 and DRB1*13:02 alleles may identify those at further increased risk of allopurinol‐induced DRESS in B*58:01 carriers. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Intratracheal administration of mesenchymal stem cells modulates lung macrophage polarization and exerts anti-asthmatic effects.
- Author
-
Mo, Yosep, Kang, Hanbit, Bang, Ji-Young, Shin, Jae Woo, Kim, Hye Young, Cho, Sang-Heon, and Kang, Hye-Ryun
- Subjects
- *
MACROPHAGES , *INNATE lymphoid cells , *T helper cells , *TH2 cells , *ALVEOLAR macrophages , *LUNGS , *MESENCHYMAL stem cells - Abstract
Mesenchymal stem cells (MSCs) possess immunomodulatory properties that have therapeutic potential for the treatment of inflammatory diseases. This study investigates the effects of direct MSC administration on asthmatic airways. Umbilical cord MSCs (ucMSCs) were intratracheally administered to six-week-old female BALB/c mice sensitized and challenged with ovalbumin; airway hyperresponsiveness (AHR), analyses of airway inflammatory cells, lung histology, flow cytometry, and quantitative real-time PCR were performed. Furthermore, ex vivo and in vitro experiments were performed to assess the effects of ucMSC on M2 activation. Intratracheally administered ucMSCs decreased degree of airway resistance and the number of inflammatory cells such as T helper 2 (Th2) cells, type 2 innate lymphoid cells (ILC2), and macrophages in the murine asthma model. Particularly, MHCII and CD86 expression diminished in dendritic cells and alveolar macrophages (AMs) following ucMSC treatment. SiglecF+CD11c+CD11b- AMs show a negative correlation with type II inflammatory cells including Th2 cells, ILC2, and eosinophils in asthmatic mice and were restored following intratracheal ucMSCs treatment. In addition, ucMSCs decreased the macrophage polarization to M2, particularly M2a. The expression levels of markers associated with M2 polarization and Th2 inflammation were also decreased. ucMSC reduced Il-12 and Tnfa expression as well as that of M2 markers such as Cd206 and Retnla ex vivo. Furthermore, the in vitro study using IL-4 treated macrophages confirmed that both direct and indirect MSC treatment significantly reduced the expression of Il-5 and Il-13. In conclusion, ucMSCs appear to suppress type II inflammation by regulating lung macrophages via soluble mediators. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Mesenchymal stem cells exert their anti-asthmatic effects through macrophage modulation in a murine chronic asthma model.
- Author
-
Kim, Ruth Lee, Bang, Ji-Young, Kim, Jeonghyeon, Mo, Yosep, Kim, Yujin, Lee, Chun-Geun, Elias, Jack A., Kim, Hye Young, and Kang, Hye-Ryun
- Subjects
- *
ASTHMA , *EOSINOPHILIA , *TRANSGENIC mice , *CORD blood , *MACROPHAGES - Abstract
Despite numerous previous studies, the full action mechanism of the pathogenesis of asthma remains undiscovered, and the need for further investigation is increasing in order to identify more effective target molecules. Recent attempts to develop more efficacious treatments for asthma have incorporated mesenchymal stem cell (MSC)-based cell therapies. This study aimed to evaluate the anti-asthmatic effects of MSCs primed with Liproxstatin-1, a potent ferroptosis inhibitor. In addition, we sought to examine the changes within macrophage populations and their characteristics in asthmatic conditions. Seven-week-old transgenic mice, constitutively overexpressing lung-specific interleukin (IL)-13, were used to simulate chronic asthma. Human umbilical cord-derived MSCs (hUC-MSCs) primed with Liproxstatin-1 were intratracheally administered four days prior to sampling. IL-13 transgenic mice demonstrated phenotypes of chronic asthma, including severe inflammation, goblet cell hyperplasia, and subepithelial fibrosis. Ly6C+M2 macrophages, found within the pro-inflammatory CD11c+CD11b+ macrophages, were upregulated and showed a strong correlation with lung eosinophil counts. Liproxstatin-1-primed hUC-MSCs showed enhanced ability to downregulate the activation of T helper type 2 cells compared to naïve MSCs in vitro and reduced airway inflammation, particularly Ly6C+M2 macrophages population, and fibrosis in vivo. In conclusion, intratracheal administration is an effective method of MSC delivery, and macrophages hold great potential as an additional therapeutic target for asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Effect of Acinetobacter lwoffii on the modulation of macrophage activation and asthmatic inflammation.
- Author
-
Kang, Hanbit, Bang, Ji‐Young, Mo, Yosep, Shin, Jae Woo, Bae, Boram, Cho, Sang‐Heon, Kim, Hye Young, and Kang, Hye‐Ryun
- Subjects
- *
MACROPHAGE activation , *TH2 cells , *ACINETOBACTER , *INTRANASAL administration , *FLOW cytometry - Abstract
Background: Although lung macrophages are directly exposed to external stimuli, their exact immunologic roles in asthma are still largely unknown. The aim of this study was to investigate the anti‐asthmatic effect of Acinetobacter lwoffii in terms of lung macrophage modulation. Methods: Six‐week‐old female BALB/c mice were sensitized and challenged with ovalbumin (OVA) with or without intranasal administration of A. lwoffii during the sensitization period. Airway hyperresponsiveness and inflammation were evaluated. Using flow cytometry, macrophages were subclassified according to their activation status. In the in vitro study, a murine alveolar macrophage cell line (MH‐S) treated with or without A. lwoffii before IL‐13 stimulation were analysed by quantitative RT‐PCR. Results: In a murine asthma model, the number of inflammatory cells, including macrophages and eosinophils, decreased in mice treated with A. lwoffii (A. lwoffii/OVA group) compared with untreated mice (OVA group). The enhanced expression of MHCII in macrophages in the OVA group was decreased by A. lwoffii treatment. M2 macrophage subtypes were significantly altered. A. lwoffii treatment decreased CD11b+M2a and CD11b+M2c macrophages, which showed strong positive correlations with Th2 cells, ILC2 and eosinophils. In contrast, CD11b+M2b macrophages were significantly increased by A. lwoffii treatment and showed strong positive correlations with ILC1 and ILC3. In vitro, A. lwoffii down‐regulated the expression of M2 markers related but up‐regulated those related to M2b macrophages. Conclusions and Clinical Relevance: Intranasal A. lwoffii exposure suppresses asthma development by suppressing the type 2 response via modulating lung macrophage activation, shifting M2a and M2c macrophages to M2b macrophages. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes.
- Author
-
Lee, Kye Hwa, Kang, Dong Yoon, Kim, Hyun Hwa, Kim, Yi Jun, Kim, Hyo Jung, Kim, Ju Han, Song, Eun Young, Yun, James, and Kang, Hye‐Ryun
- Subjects
- *
DRUG side effects , *HLA histocompatibility antigens , *ELECTRONIC health records , *GENOTYPES , *DRUG utilization , *RISK perception - Abstract
Background: Several type B adverse drug reactions (ADRs), especially severe cutaneous adverse reactions (SCARs), are associated with particular human leukocyte antigen (HLA) genotypes. However, pre‐stored HLA information obtained from other clinical workups has not been used to prevent ADRs. We aimed to simulate the preemptive use of pre‐stored HLA information in electronic medical records to evaluate whether this information can prevent ADRs. Methods: We analyzed the incidence and the risk of ADRs for selected HLA alleles (HLA‐B*57:01, HLA‐B*58:01, HLA‐A*31:01, HLA‐B*15:02, HLA‐B*15:11, HLA‐B*13:01, HLA‐B*59:01, and HLA‐A*32:01) and seven drugs (abacavir, allopurinol, carbamazepine, oxcarbazepine, dapsone, methazolamide, and vancomycin) using pre‐stored HLA information of transplant patients based on the Pharmacogenomics Knowledge Base guidelines and experts' consensus. Results: Among 11,988 HLA‐tested transplant patients, 4092 (34.1%) had high‐risk HLA alleles, 4583 (38.2%) were prescribed risk drugs, and 580 (4.8%) experienced type B ADRs. Patients with HLA‐B*58:01 had a significantly higher incidence of type B ADR and SCARs associated with allopurinol use than that of patients without HLA‐B*58:01 (17.2% vs. 11.9%, odds ratio [OR] 1.53 [95% confidence interval {CI} 1.09–2.13], p = 0.001, 2.3% versus 0.3%, OR 7.13 [95% CI 2.19–22.69], p < 0.001). Higher risks of type B ADR and SCARs were observed in patients taking carbamazepine or oxcarbazepine if they had one of HLA‐A*31:01, HLA‐B*15:02, or HLA‐B*15:11 alleles. Vancomycin and dapsone use in HLA‐A*32:01 and HLA‐B*13:01 carriers, respectively, showed trends toward increased risk of type B ADRs. Conclusion: Utilization of pre‐stored HLA data can prevent type B ADRs including SCARs by screening high‐risk patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Transglutaminase 2 mediates lung inflammation and remodeling by transforming growth factor beta 1 via alveolar macrophage modulation.
- Author
-
Kim, Young Chan, Kim, Jeonghyeon, Kim, Subin, Bae, Boram, Kim, Ruth Lee, Jeong, Eui-Man, Cho, Sang-Heon, and Kang, Hye-Ryun
- Subjects
- *
TRANSFORMING growth factors-beta , *PNEUMONIA , *ALVEOLAR macrophages , *FIBROBLAST growth factors , *MACROPHAGES - Abstract
Transforming growth factor beta 1 (TGF-β1) induces pulmonary fibrosis by enhancing epithelial apoptosis and affects the enzymatic activity of transglutaminase 2 (TG2). The aim of this study was to determine the role of TG2 in TGF-β1-induced lung remodeling and alveolar macrophage modulation. We characterized the in vivo effects of TGF-β1 and TG2 on lung inflammation, fibrosis, and macrophage activity using transgenic C57BL/6 mice with wild and null TG2 loci. The effect of TG2 inhibition on in vitro TGF-β1-stimulated alveolar macrophages was assessed through mRNA analysis. TG2 was remarkably upregulated in the lungs of TGF-β1 transgenic (TGF-β1 Tg) mice, especially in alveolar macrophages and epithelial cells. In the absence of TG2, TGF-β1-induced inflammation was suppressed, decreasing the number of macrophages in the bronchoalveolar lavage fluid. In addition, the alveolar destruction and peribronchial fibrosis induced by TGF-β1 overexpression were significantly reduced, which correlated with decreases in the expression of fibroblast growth factor and matrix metallopeptidase 12, respectively. However, TG2 deficiency did not compromise the phagocytic activity of alveolar macrophages in TGF-β1 Tg mice. At the same time, TG2 contributed to the regulation of TGF-β1-induced macrophage activation. Inhibition of TG2 did not affect the TGF-β1-induced expression of CD86, an M1 marker, in macrophages, but it did reverse the TGF-β1-induced expression of CD206. This result suggests that TG2 mediates TGF-β1-induced M2-like polarization but does not contribute to TGF-β1-induced M1 polarization. In conclusion, TG2 regulates macrophage modulation and plays an important role in TGF-β1-induced lung inflammation, destruction, and fibrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. The Usefulness of Job Relocation and Serum Eosinophil Cationic Protein in Baker's Asthma.
- Author
-
Kim, Min-Hye, Jung, Jae-Woo, and Kang, Hye-Ryun
- Subjects
- *
EOSINOPHILIA , *BASIC proteins , *OCCUPATIONAL asthma , *BUSINESS relocation , *METHACHOLINE chloride - Abstract
Background: Although the most widely recommended treatment for occupational asthma is to completely avoid the causative agents, job relocation within the same company is often substituted for a complete career change. However, there is not much data on the efficacy of job relocation within the workplace and appropriate follow-up parameters. We investigated baker's asthma patients to validate the efficacy of job relocation and follow-up markers. Methods: Twelve bakery plant workers diagnosed with baker's asthma were enrolled in the study. Asthma-related symptoms and methacholine provocation test were followed up 6 months after a job relocation. Skin prick test and ELISA to detect wheat flour-specific IgE and eosinophil cationic protein (ECP) in sputum and serum were also followed up to evaluate the status of allergic inflammation. Results: After a 6-month job relocation, all 12 workers showed an improvement in symptoms, and airway hyperresponsiveness to methacholine was negatively converted in 9 of them. There were no significant differences in skin reactivity and serum flour-specific IgE levels before and after the relocation. While sputum ECP levels did not show a significant difference (338.3 ± 93.0 μg/l vs. 175.0 ± 78.9 μg/l, p = 0.118), there was a remarkable difference in serum ECP levels before and after the relocation (12.2 ± 3.0 μg/l vs. 2.8 ± 3.1 μg/l, p = 0.004). Conclusions: Job relocation was effective in managing baker's asthma. Serum ECP level was a useful follow-up marker of baker's asthma. Copyright © 2013 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
19. Tranglutaminase 2 contributes to the asthmatic inflammation by modulating activation of alveolar macrophages.
- Author
-
Lee, Hyun Seung, Park, Da‐Eun, Bae, Boram, Oh, Keunhee, Jung, Jae Woo, Lee, Dong‐Sup, Kim, In‐Gyu, Cho, Sang‐Heon, and Kang, Hye‐Ryun
- Subjects
- *
ALVEOLAR macrophages , *OVALBUMINS , *MACROPHAGE activation , *ASTHMA , *ASTHMATICS , *EOSINOPHILS , *COUGH - Abstract
Background: Transglutaminase 2 (TG2), a multifunctional calcium‐dependent acyltransferase, is upregulated in asthmatic airways and reported to play a role in the pathogenesis of allergic asthma. However, the underlying mechanism is not fully understood. Objective: To investigate the role of TG2 in alternative activation of alveolar macrophages by using murine asthma model. Methods: TG2 expression was assessed in induced sputum of 21 asthma patients and 19 healthy controls, and lung tissue of ovalbumin (OVA)‐induced murine asthma model. To evaluate the role of TG2 in asthma, we developed an OVA asthma model in both TG2 null and wild‐type mice. The expression of M2 macrophage markers was measured by fluorescence‐activated cell sorting (FACS) after OVA sensitization and challenge. To evaluate the effect of TG2 inhibition in vitro, interleukin 4 (IL‐4) or IL‐13‐stimulated expression of M2 macrophage markers was measured in CRL‐2456 cells in the presence and absence of a TG2 inhibitor. Results: The expression of both TG2 and M2 markers was increased in the sputum of asthmatics compared with that of healthy controls. The expression of TG2 was increased in macrophages of OVA mice. Airway hyperresponsiveness, and the number of inflammatory cells, including eosinophils, was significantly reduced in TG2 null mice compared with wild‐type mice. Enhanced expression of M2 markers in OVA mice was normalized by TG2 knockout. IL‐4 or IL‐13‐stimulated expression of M2 markers in alveolar macrophages was also attenuated by TG2 inhibitor treatment in vitro. Conclusion: Our results suggest that TG2‐mediated modulation of alveolar macrophage polarization plays important roles in the pathogenesis of asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. Ultra-high-resolution computed tomography shows changes in the lungs related with airway hyperresponsiveness in a murine asthma model.
- Author
-
Jung, Jae-Woo, Oh, Jung Suk, Bae, Boram, Ahn, Yoon Hae, Kim, Lucy Wooyeon, Choi, Jiwoong, Kim, Hye-Young, Kang, Hye-Ryun, and Lee, Chang Hyun
- Subjects
- *
ASTHMA treatment , *COMPUTED tomography , *LUNG physiology , *OVALBUMINS , *DRUG delivery systems - Abstract
In vivo presentation of airway hyper-responsiveness (AHR) at the different time points of the allergic reaction is not clearly understood. The purpose of this study was to investigate how AHR manifests in the airway and the lung parenchyma in vivo following exposure to different stimuli and in the early and late phases of asthma after allergen exposure. Ovalbumin (OVA)-induced allergic asthma model was established using 6-week female BALB/c mice. Enhanced pause was measured with a non-invasive method to assess AHR. The dynamic changes of the airway and lung parenchyma were evaluated with ultra-high-resolution computed tomography (128 multi-detector, 1024 × 1024 matrix) for 10 h. While the methacholine challenge showed no grossly visible changes in the proximal airway and lung parenchyma despite provoking AHR, the OVA challenge induced significant immediate changes manifesting as peribronchial ground glass opacities, consolidations, air-trapping, and paradoxical proximal airway dilatations. After resolution of immediate response, multiple episodes of AHRs occurred with paradoxical proximal airway dilatation and peripheral air-trapping in late phase over a prolonged time period in vivo. Understanding of airflow limitation based on the structural changes of asthmatic airway would be helpful to make an appropriate drug delivery strategy for the treatment of asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity.
- Author
-
Torres, María José, Trautmann, Axel, Böhm, Ingrid, Scherer, Kathrin, Barbaud, Annick, Bavbek, Sevim, Bonadonna, Patrizia, Cernadas, Josefina Rodrigues, Chiriac, Anca Mirela, Gaeta, Francesco, Gimenez‐Arnau, Ana M., Kang, Hye‐Ryun, Moreno, Esther, and Brockow, Knut
- Subjects
- *
CONTRAST media , *ALLERGIES , *DIAGNOSIS , *RISK assessment , *CLINICAL drug trials - Abstract
Immediate and nonimmediate hypersensitivity reactions to iodinated contrast media (ICM) have been reported to occur in a frequency of about 0.5%‐3% of patients receiving nonionic ICM. The diagnosis and management of these patients vary among guidelines published by various national and international scientific societies, with recommendations ranging from avoidance or premedication to drug provocation test. This position paper aims to give recommendations for the management of patients with ICM hypersensitivity reactions and analyze controversies in this area. Skin tests are recommended as the initial step for diagnosing patients with immediate and nonimmediate hypersensitivity reactions; besides, they may also help guide on tolerability of alternatives. Re‐exposition or drug provocation test should only be done with skin test‐negative ICMs. The decision for performing either re‐exposition or drug provocation test needs to be taken based on a risk‐benefit analysis. The role of in vitro tests for diagnosis and pretreatment for preventing reactions remains controversial. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. Microbiome profiling of uncinate tissue and nasal polyps in patients with chronic rhinosinusitis using swab and tissue biopsy.
- Author
-
Cho, Sung-Woo, Kim, Dong-Young, Choi, Sungmi, Won, Sungho, Kang, Hye-Ryun, and Yi, Hana
- Subjects
- *
NASAL polyps , *NASAL mucosa , *SINUSITIS , *BACTERIAL diversity , *BIOPSY , *TISSUES - Abstract
Chronic rhinosinusitis (CRS) is characterized according to the presence or absence of nasal polyps (NPs) and displays nasal microbiota dysbiosis. However, optimal sampling methods of the nasal microbiome in CRS have not been identified. We aimed to assess the microbial composition in patients with CRS, comparing different sampling methods (swab and tissue biopsy), tissue types (uncinate tissue and NP), and disease subtypes. Samples were obtained by swabbing the middle meatus and taking a biopsy of uncinate tissue (UT) in patients with CRS with (CRSwNP, N = 8) or without NP (CRSsNP, N = 6) and controls (N = 8). NPs were also harvested in CRSwNP. DNAs were extracted from fifty-two samples and analyzed by 16S rRNA gene amplicon sequencing. As a result, a great interpersonal variance was observed in nasal swabs, while UT samples presented distinct microbiome with low inter-personal differences. Moreover, the UT microbiomes were further differentiated into three clusters which are associated with disease status (control, CRSsNP, and CRSwNP). Compared to UT, NP revealed a unique microbiome profile with significantly less bacterial diversity. Prevotella was the genus whose abundance was negatively correlated with disease severity in NP. In conclusion, tissue samples are better specimens than nasal swabs for assessing the microbiomes of CRS patients. Several bacteria in UT and NP tissues revealed an association with clinical severity of CRSwNP. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Analysis of Innate and Adaptive Immunological Characteristics in Patients with IgG4-Related Disease.
- Author
-
Sohn, Kyoung-Hee, Ham, Jongho, Chung, Soo Jie, Kang, Hye-Ryun, and Kim, Hye Young
- Subjects
- *
T helper cells , *INNATE lymphoid cells , *CELL populations , *B cells , *T cells - Abstract
Background: Immunoglobulin G4-related disease (IgG4-RD) is a systemic immunological disorder characterized by fibro-inflammatory conditions; however, the pathobiology of IgG4-RD has not been fully identified. Objective: This study aimed to analyze systemic differences of innate and adaptive immune cells from healthy controls and patients with IgG4-RD. Methods: Healthy controls (n = 9) and IgG4-RD patients (n = 7) were recruited with informed consent. Peripheral blood was collected from healthy controls and IgG4-RD patients, and three blood samples from IgG4-RD patients were re-collected two months after the last rituximab (RTX) treatment. The various immune cells and cytokine productions were measured by flow cytometry. Results: Blood CD14+ monocytes and steady-state follicular helper T cells were increased in patients with IgG4-RD. However, there were no changes in other immune cell populations, including B cells, CD4 T cells, CD8 T cells, and innate lymphoid cells. Also, the TGF-β-producing CD14+ monocytes were significantly augmented in patients with IgG4-RD. Two months after RTX treatment, total B cells (CD19+) were depleted; however, the expressions of TGF-β from CD14+ monocytes remained unchanged. Conclusion: These findings showed that IgG4-RD is related to the increment of CD14+ monocytes. Besides, controlling increased TGF-β-producing CD14+ monocytes with RTX treatment might be a conducive way to regulate IgG4-RD. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
24. The effect of air pollutants on airway innate immune cells in patients with asthma.
- Author
-
Kim, Jihyun, Kim, Young‐Chan, Ham, Jongho, Sohn, Kyoung‐Hee, Lee, Suh‐Young, Chung, Doo Hyun, Cho, Sang‐Heon, Kang, Hye Ryun, and Kim, Hye Young
- Subjects
- *
AIR pollutants , *ASTHMATICS , *INDOOR air pollution , *PSYCHONEUROIMMUNOLOGY , *POLLUTANTS , *INNATE lymphoid cells - Published
- 2020
- Full Text
- View/download PDF
25. Aggravation of asthmatic inflammation by chlorine exposure via innate lymphoid cells and CD11cintermediate macrophages.
- Author
-
Shim, Ji‐Su, Lee, Hyun‐Seung, Park, Da‐Eun, Won Lee, Ji, Bae, Boram, Chang, Yuna, Kim, Jihyun, Kim, Hye Young, and Kang, Hye‐Ryun
- Subjects
- *
INNATE lymphoid cells , *CHLORINE , *TH2 cells , *CELL populations , *DISEASE resistance of plants - Abstract
Background: Chlorine is widely used in daily life as disinfectant. However, chronic exposure to chlorine products aggravates allergic TH2 inflammation and airway hyperresponsiveness (AHR). Innate lymphoid cells (ILCs) in airways contribute to the inception of asthma in association with virus infection, pollution, and excess of nutrient, but it is not known whether chronic chlorine exposure can activate innate immune cells. The aim of this study was to evaluate the impact of chlorine inhalation on the innate immunity such as ILCs and macrophages in relation with the development of asthma by using murine ovalbumin (OVA) sensitization/challenge model. Methods: Six‐week‐old female BALB/c mice were sensitized and challenged with OVA in the presence and absence of chronic low‐dose chlorine exposure by inhalation of naturally vaporized gas of 5% sodium hypochlorite solution. AHR, airway inflammatory cells, from BALF and the population of ILCs and macrophages in the lung were evaluated. Results: The mice exposed to chlorine with OVA (Cl + OVA group) showed enhanced AHR and eosinophilic inflammation compared to OVA‐treated mice (OVA group). The population of TH2 cells, ILC2s, and ILC3s increased in Cl + OVA group compared with OVA group. CD11cint macrophages also remarkably increased in Cl + OVA group compared with OVA group. The deletion of macrophages by clodronate resulted in reduction of ILC2s and ILC3s population which was restored by adoptive transfer of CD11cint macrophages. Conclusions: Chronic chlorine inhalation contributes to the exacerbation of airway inflammation in asthmatic airway by mobilizing pro‐inflammatory macrophage into the lung as well as stimulating group 2 and 3 ILCs. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
26. Duration of Observation for Detecting a Biphasic Reaction in Anaphylaxis: A Meta-Analysis.
- Author
-
Kim, Tae-Hyung, Yoon, Soon Ho, Hong, Hyunsook, Kang, Hye-Ryun, Cho, Sang-Heon, and Lee, Suh-Young
- Subjects
- *
ANAPHYLAXIS , *META-analysis , *WORKING hours - Abstract
Background: We conducted a meta-analysis to determine a practical observation time for detecting a biphasic reaction after resolution of the initial anaphylactic reaction. Methods: A systematic literature search identified studies on adult patients with anaphylaxis and a subsequent biphasic reaction due to various causes that contained sufficient data to extract outcomes. The outcomes were pooled using a random-effects model. Results: Twelve studies with a total of 2,890 adult patients with anaphylaxis and 143 patients with a biphasic reaction were included. In terms of the pooled negative predictive value, 1 h of observation achieved a 95.0% negative predictive value and ≥6 h of observation provided a 97.3% negative predictive value (95% CI: 95.0–98.5). The negative predictive value for a biphasic reaction increased with a longer observation time after initial anaphylaxis, and the increasing trend slowed down from 6 h of observation time. The pooled additional incidence rates of biphasic reactions per 100 person-hours after 1- and 4-h observations were 0.45 (95% CI: 0.20–1.04) and 0.41 (95% CI: 0.19–0.87), respectively. After > 8–12 h of postanaphylactic observation, the negative predictive value reached > 98%, while the additional incidence per 100 person-hours was < 0.10. Conclusions: An observation time of ≥6 h after resolution of an initial anaphylaxis symptom can exclude recurrence of a secondary reaction in > 95% of patients. Although longer observation periods resulted in the detection of more biphasic reactions, 6–12 h of observation time would be practical, supporting current relevant guidelines. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
27. Immediate and delayed hypersensitivity after intra-arterial injection of iodinated contrast media: a prospective study in patients with coronary angiography.
- Author
-
Sohn, Kyoung-Hee, Kim, Gun-Woo, Lee, Suh-Young, Kim, Hyo-Soo, Cho, Sang-Heon, Han, Jung-Kyu, and Kang, Hye-Ryun
- Subjects
- *
DELAYED hypersensitivity , *CONTRAST media , *ALLERGIES , *CORONARY angiography , *INTRA-arterial injections - Abstract
Objectives: While hypersensitivity reactions (HSR) to intravenously administered iodinated contrast media (ICM) have been well studied, not much is known about HSR to intra-arterially administered ICM. Methods: A prospective observational study was performed to evaluate coronary angiography (CAG)-induced ICM hypersensitivity in patients who underwent CAG using ICM including ioversol, a low-osmolar non-ionic monomer, and iodixanol, an iso-osmolar non-ionic dimer. The HSR were investigated through in-patient monitoring after CAG and telephone interview after discharge. Results: A total of 714 patients were enrolled during the observation period, of whom 26 (3.6%) showed immediate HSR and 108 (15.1%) showed delayed HSR. With regard to severity, proportion of immediate HSR grades 1, 2, and 3 was 57.7%, 38.5%, and 3.8%, respectively, whereas that of delayed HSR grades 1, 2, and 3 was 85.2%, 13.9%, and 0.9%, respectively. Multivariate analysis revealed that previous intra-arterial exposure to ICM was an independent risk factor for immediate HSR (odds ratio (OR) 2.92, 95% confidence interval (CI) 1.22–6.96; p = 0.015). Iodixanol was a significant risk factor for delayed HSR (OR 1.61, 95% CI 1.07–2.43; p = 0.024) and correlated with a higher incidence of delayed HSR within 24-h post-ICM administration compared to ioversol. Conclusion: The incidence rate of immediate and delayed HSR in intra-arterially administered ICM was 3.6% and 15.1%, respectively. Previous exposure to intra-arterially administered contrast media was a significant risk factor for immediate HSR. Compared to ioversol, iodixanol was associated with relatively earlier and more frequent delayed HSR. Key Points: • In this prospective study, the incidence of immediate and delayed hypersensitivity in intra-arterial injection of contrast media during coronary angiography was 3.6% and 15.1%, respectively. • Delayed hypersensitivity reactions were more common but less severe than immediate hypersensitivity reactions during coronary angiography. • Previous exposure to ICM via intra-arterial route was a significant risk factor for immediate hypersensitivity to intra-arterial contrast medium. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
28. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
- Author
-
Chung, Soo Jie, Kang, Sung-Yoon, Kang, Rae-Young, Kim, Young-Chan, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, and Kang, Hye-Ryun
- Subjects
- *
PLATINUM , *ALLERGIES , *DRUG allergy , *ANTINEOPLASTIC agents , *ALLERGY desensitization , *IMMUNOLOGIC diseases , *DRUG side effects - Abstract
Purpose: Desensitization is a safe alternative for patients with hypersensitivity reactions (HSRs) to platinum-based chemotherapeutic agents and widely used in real practice by employing stepwise administration of multiple serial dilutions of the culprit drugs. However, its labor-intensive nature has required a simpler protocol that is easier to prepare and perform.Methods: We performed an observational study of patients with platinum HSR who underwent a new non-dilution one-bag desensitization protocol. Premedication consisted of Montelukast as well as H1 and H2 blockers. The outcomes and safety profiles of a new protocol were assessed.Results: A total of 36 patients were recruited (oxaliplatin 23, carboplatin 9, and cisplatin 4) and the most common grade of HSR presented was grade 2 (61.1%), followed by grade 3 (25%), and grade 1 (13.9%). Of 175 desensitization procedures, all cases were successfully completed in re-administration of culprit chemotherapeutic platinum agents; 146 (83.4%) had no breakthrough reactions (BTRs) while 29 (16.6%) did. Most BTRs were mild reactions (grade 1, 51.7%) or moderate reactions (grade 2, 44.8%) of Brown's Scale. Although there was one case of asymptomatic mild hypotension (grade 3, 3.5%), categorized as severe reaction, dyspnea, desaturation, and anaphylaxis did not occur. The proportion of severe HSRs was significantly lower than that of initial HSRs (3.5% vs. 25%, P = 0.0167).Conclusions: The new non-dilution desensitization protocol was safe and effective for re-administration of culprit platinum agents in patients with a history of HSRs. Therefore, this new protocol can be used as an alternative to existing protocols using multiple serial dilutions. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
29. Biphasic and protracted anaphylaxis to iodinated contrast media.
- Author
-
Kim, Tae-Hyung, Yoon, Soon Ho, Lee, Suh-Young, Choi, Young Hun, Park, Chang Min, Kang, Hye-Ryun, and Cho, Sang-Heon
- Subjects
- *
ANAPHYLAXIS , *RADIOLOGY , *DRUG side effects , *EPIDEMIOLOGY , *ANTI-inflammatory agents - Abstract
Objectives: To investigate the prevalence of biphasic and protracted anaphylaxis to iodinated contrast media (ICM), their risk factors and practical observation duration for detecting biphasic reaction.Methods: 145 patients with ICM anaphylaxis from January 2005-February 2016 were retrospectively categorised into uniphasic, biphasic (anaphylaxis recurrence within 72 h after resolution of initial anaphylaxis) and protracted (anaphylaxis >5 h) reaction groups. Multivariate regression analyses of potential risk factors were performed. We calculated negative predictive value (NPV) for biphasic reactions and additional person-hours required to detect one case during post-anaphylaxis observation.Results: Fifteen patients had biphasic reactions with secondary reactions with similar or milder severity and six had protracted reactions. Most significant risk factors were anaphylaxis duration >40 min for biphasic reactions (odds ratio (OR), 8.65 [95 % CI, 1.05-70.71]; P=0.044), and additional epinephrine administration within 1 h of initial dosing for protracted reactions (OR, 102.0 [95 % CI, 3.40-3057.25]; P=0.008). A 6-h post-anaphylaxis observation produced NPV of 96.4 %, while requiring a minimum of 65.5 additional person-hours to detect one additional case.Conclusion: Biphasic and protracted ICM anaphylaxis developed in 10.3 % and 4.1 %, respectively, with revealing risk factors. Six hours could be practical for post-anaphylaxis observation to detect biphasic reaction.Key Points: • Incidence of biphasic anaphylaxis in iodinated contrast media anaphylaxis is 10.3 %. • Incidence of protracted anaphylaxis in iodinated contrast media anaphylaxis is 4.1 %. • Initial anaphylaxis >40 min can predict for biphasic anaphylaxis development. • A 6-h post-anaphylactic observation in ICM-related anaphylaxis seems practical. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
30. Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing.
- Author
-
Lee, Jee-Soo, Seo, Heewon, Im, Kyongok, Park, Si Nae, Kim, Sung-Min, Lee, Eun Kyoung, Kim, Jung-Ah, Lee, Joon-hee, Kwon, Sunghoon, Kim, Miyoung, Koh, Insong, Hwang, Seungwoo, Park, Heung-Woo, Kang, Hye-Ryun, Park, Kyoung Soo, Kim, Ju Han, and Lee, Dong Soon
- Subjects
- *
HYPEREOSINOPHILIC syndrome , *GENE targeting , *EOSINOPHILS , *CELL proliferation , *GENETIC mutation , *NUCLEOTIDE sequencing - Abstract
Idiopathic hypereosinophilia (IHE)/idiopathic hypereosinophilic syndrome (IHES) has been defined by a persistent elevation of the blood eosinophil count exceeding 1.5×103/μL, without evidence of reactive or clonal causes. While T-cell clonality assessment has been recommended for unexplained hypereosinophilia, this approach is not often applied to routine practice in the clinic. We hypothesized that the clonality would exist in a subset of IHE/IHES patients. We aimed to investigate the candidate mutations and T-cell clonality in IHE/IHES and to explore the role of mutations in eosinophil proliferation. We performed targeted capture sequencing for 88 genes using next-generation sequencing, T-cell receptor (TCR) gene rearrangement assays, and pathway network analysis in relation to eosinophil proliferation. By targeted sequencing, 140 variants in 59 genes were identified. Sixteen out of 30 patients (53.3%) harbored at least one candidate mutation. The most frequently affected genes were NOTCH1 (26.7%), SCRIB and STAG2 (16.7%), and SH2B3 (13.3%). Network analysis revealed that our 21 candidate genes (BIRC3, BRD4, CSF3R, DNMT3A, EGR2, EZH2, FAT4, FLT3, GATA2, IKZF, JAK2, MAPK1, MPL, NF1, NOTCH1, PTEN, RB1, RUNX1, TET2, TP53 and WT1) are functionally linked to the eosinophilopoietic pathway. Among the 21 candidate genes, five genes (MAPK1, RUNX1, GATA2, NOTCH1 and TP53) with the highest number of linkages were considered major genes. A TCR assay revealed that four patients (13.3%) had a clonal TCR rearrangement. NOTCH1 was the most frequently mutated gene and was shown to be a common node for eosinophilopoiesis in our network analysis, while the possibility of hidden T cell malignancy was indwelling in the presence of NOTCH1 mutation, though not revealed by aberrant T cell study. Collectively, these results provide new evidence that mutations affecting eosinophilopoiesis underlie a subset of IHE/IHES, and the candidate genes are inferred to act their potential roles in the eosinophilopoietic pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
31. Epidemiology of drug-induced anaphylaxis in a tertiary hospital in Korea.
- Author
-
Park, Han-Ki, Kang, Min-Gyu, Yang, Min-Suk, Jung, Jae-Woo, Cho, Sang-Heon, and Kang, Hye-Ryun
- Subjects
- *
DRUG-induced abnormalities , *EPIDEMIOLOGY , *ANAPHYLAXIS , *ALLERGIES , *PATIENTS , *DISEASE risk factors - Abstract
Background Epidemiology and risk factors of drug-induced anaphylaxis are difficult to estimate due to lack of confirmative diagnosis and under reporting. Here we report the current state of drug-induced anaphylaxis in Korea based on an in-hospital pharmacovigilance database in a tertiary hospital. Methods This study is a retrospective analysis of drug-induced anaphylaxis, reported to an in-hospital pharmacovigilance center in Seoul National University Hospital from June 2009 to May 2013. Anaphylaxis occurred in patients under 18 years of age or developed by medications administered from outside pharmacies or hospitals were excluded. We assessed causative drug, incidence per use of each drug and risk factors of fatal anaphylactic shock. Results A total of 152 in-hospital drug-induced anaphylaxis cases were reported during the study period. The single most frequently reported drug was platinum compound and the incidence of anaphylaxis and anaphylactic shock in platinum compounds users was 2.84 and 1.39 per 1000 patients use. Risk factors of anaphylactic shock among total anaphylaxis cases were identified as older age ≥70 years [Odd's ratio (OR), 5.86; 95% confidence interval (CI), 1.70–20.14]. The use of iodinated contrast media (OR, 6.19; 95% CI, 1.87–20.53) and aminosteroid neuromuscular blocking agent (NMBA) (OR, 12.82; 95% CI, 1.50–109.92) were also a risk factor for the development of anaphylactic shock. Conclusions Platinum compounds are the most commonly reported causative agents of in-hospital drug-induced anaphylaxis. Older age ≥70 years and drugs such as iodinated contrast media and aminosteroid NMBA are related with high risk of anaphylactic shock. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
32. Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: A multicentre retrospective cohort study.
- Author
-
Park, Hye, Park, Jung-Won, Yang, Min-Suk, Kim, Mi-Yeong, Kim, Sae-Hoon, Jang, Gwang, Nam, Young-Hee, Kim, Gun-Woo, Kim, Sujeong, Park, Hye-Kyung, Jung, Jae-Woo, Park, Jong-Sook, Kang, Hye-Ryun, Park, Hye Jung, and Jang, Gwang Cheon
- Subjects
- *
ALLERGY diagnosis , *CONTRAST-enhanced magnetic resonance imaging , *ALLERGIES , *DRUG allergy , *COMPUTED tomography , *CONTRAST media - Abstract
Objectives: To evaluate the outcomes of re-exposure to low-osmolar iodinated contrast medium (LOCM) in patients with a history of moderate-to-severe hypersensitivity reaction (HSR).Methods: We retrospectively evaluated a cohort comprising all subjects satisfying the following conditions at 11 centres: (1) experienced a moderate-to-severe HSR to LOCM by December 2014, and (2) underwent contrast-enhanced computed tomography after the initial HSR between January 2014 and December 2014.Results: A total of 150 patients with 328 instances of re-exposure were included; the recurrence rate of HSR was 19.5%. Patients with severe initial HSR exhibited a higher recurrence rate of severe HSR compared to patients with moderate initial HSR, despite more intensive premedication. In the multivariate analysis, the independent risk factors for recurrence of HSR were diabetes, chronic urticaria, drug allergy other than to iodinated contrast media (ICM) and severe initial HSR. The risk of recurrent HSR was 67.1% lower in cases where the implicated ICM was changed to another one (odds ratio: 0.329; P = 0.001). However, steroid premedication did not show protective effects against recurrent HSR.Conclusion: In high-risk patients who have previously experienced a moderate-to-severe initial HSR to LOCM, we should consider changing the implicated ICM to reduce recurrence risk.Key Points: • In patients with moderate-to-severe HSR, steroid premedication only shows limited effectiveness. • Changing the implicated ICM can reduce the recurrence of HSR to ICM. • Diabetes, chronic urticaria and drug allergies increase the risk of ICM HSR. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
33. Clinical profiles of adverse drug reactions spontaneously reported at a single Korean hospital dedicated to children with complex chronic conditions.
- Author
-
Kim, Bomi, Kim, Sunwha Zara, Lee, Jin, Jung, Ae Hee, Jung, Sun-Hoi, Hahn, Hyeon-Joo, Kang, Hye Ryun, and Suh, Dong In
- Subjects
- *
DRUG side effects , *CHRONIC diseases in children , *HOSPITALS , *IMMUNOREGULATION , *ANTINEOPLASTIC agents - Abstract
Children with complex chronic conditions (CCC) are presumed to be vulnerable to adverse drug reactions (ADRs). The clinical profiles of ADRs in CCC are not well known. Herein, we aim to describe the ADR profiles in CCC with regard to typical presentations and vulnerable groups. We accessed the ADR yearly reports at a tertiary children's hospital whose practice is mainly dedicated to CCC and descriptively analyzed their clinical profiles according to the presence of a complex chronic condition, ADR severity, and age groups. A total of 1841 cases were analyzed, among which 1258 (68.3%) were mild, 493 (26.8%) moderate, and 90 (4.9%) cases were severe. A total of 1581 (85.9%) cases of complex chronic condition were reported. The proportion of CCC in each severity group increased as the ADR becomes more severe. In CCC, ADRs were most frequently reported by nurses in the adolescent group and in cases where the symptoms involved the gastrointestinal system. The class of antineoplastic and immunomodulating drugs was the most commonly suspected of causing an ADR, followed by one of the antibiotics. When we focus on the trend across the age groups, the ratio of severe-to-total ADRs decreased with older age. Among severe cases, the ratio of off-label prescription-related cases was the highest in the infant/toddler group and decreased as the groups aged. In conclusion, ADRs of CCCs admitted to a tertiary children’s hospital have a unique profile. These groups are vulnerable to ADRs and thus they should be monitored closely, especially when they are infants or toddlers, so that severe ADRs can be identified and treated immediately. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
34. Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea.
- Author
-
Yang, Min-Suk, Lee, Jin Yong, Kim, Jayeun, Kim, Gun-Woo, Kim, Byung-Keun, Kim, Ju-Young, Park, Heung-Woo, Cho, Sang-Heon, Min, Kyung-Up, and Kang, Hye-Ryun
- Subjects
- *
STEVENS-Johnson Syndrome , *DISEASE incidence , *DEATH rate , *DISEASE complications - Abstract
Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening diseases; however, it is hard to estimate their incidence due to the rarity of these diseases. We evaluated the incidence of SJS and TEN using a nationwide administrative database. Methods: We used a national medical insurance review system (Health Insurance Review and Assessment) database which contained the claim data of the entire nation from 2009 to 2013 to estimate the accurate incidence of SJS and TEN in Korea. The diagnostic codes of L511 (SJS) or L512 (TEN) from the International Classification of Diseases-10th revision were used to define the target study population. We also retrospectively followed up a 2011 SJS and TEN cohort for 24 months in order to assess the in-hospital mortality, related complications and total claims cost due to SJS and TEN. Results: A total of 1,167 (938 SJS and 229 TEN) cases were newly diagnosed from 2010 to 2013. The age- and sex-standardized annual incidences estimated in this study were 3.96 to 5.03 in SJS and 0.94 to 1.45 in TEN per million. There was no significant change in annual incidence throughout the study periods. When analyzed by 10-year age groups, the annual incidence was the lowest in group 20–29 years and the highest in group 70 for both SJS and TEN. Based on the 2011 cohort analysis, the in-hospital mortality were 5.7 and 15.1% for SJS and TEN, respectively. The mortality increased with age, particularly, after 40 years of age. Among the complications related with SJS or TEN, ocular sequelae was the most common (43.1 and 43.4% of SJS and TEN patients, respectively) followed by urethral sequelae (5.7 and 9.4% of SJS and TEN patients, respectively). Conclusion: Overall, our data suggest that SJS, and TEN are infrequent but constantly arise throughout the years. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
35. Allergies are still on the rise? A 6-year nationwide population-based study in Korea.
- Author
-
Kim, Byung-Keun, Kim, Ju-Young, Kang, Min-Koo, Yang, Min-Suk, Park, Heung-Woo, Min, Kyung-Up, Cho, Sang-Heon, and Kang, Hye-Ryun
- Subjects
- *
ALLERGIES , *SKIN inflammation - Abstract
Background Some western countries recently have shown a slowdown in the incidence of allergic diseases after worldwide increasing trends, but there are few data from Asian populations concerning changing trend of allergic diseases. We evaluated the recent trends in the prevalence of asthma and other allergic diseases in Korea. Methods From the database of Korean National Health Insurance, a nationwide diagnostic data from 2009 to 2014 were extracted and the national prevalence was analyzed. Results The prevalence per 1000 people of atopic dermatitis, allergic rhinitis, and asthma in 2014 was 19.0, 133.1, and 36.3, respectively. The prevalence of three diseases was highest in the age group under 10 as, 95.0, 384.1, and 132.1 per 1000 people, while the prevalence in the over-10-year-group was only 11.6, 109.5, and 27.3, respectively. The prevalence of atopic dermatitis and allergic rhinitis gradually decreased with older age, but the prevalence of asthma showed a re-increasing pattern from the age group 30–39 and reached another peak for the age group 70–79. During the study period, the prevalence of asthma and atopic dermatitis showed decreasing tendency. In contrast, the prevalence of allergic rhinitis steadily increased until 2013, especially in the age group under 10. Conclusions The national prevalence of atopic dermatitis, and asthma did not show noticeable increase any more in Korea. However, the prevalence of allergic rhinitis still on the rise until recently, especially in the age group under 10. This is the first report in Asia suggesting a slowdown of the incidence of allergic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
36. TNF-α enhance Th2 and Th17 immune responses regulating by IL23 during sensitization in asthma model.
- Author
-
Lee, Hyun Seung, Park, Heung-Woo, Song, Woo-Jung, Jeon, Eun Young, Bang, Boram, Shim, Eun-jin, Moon, Hyung-Geun, Kim, Yoon-Keun, Kang, Hye-Ryun, Min, Kyung-Up, and Cho, Sang-Heon
- Subjects
- *
IMMUNOREGULATION , *INTERLEUKIN-23 , *TH2 cells , *TUMOR necrosis factors , *ASTHMA , *LABORATORY rats , *AIRWAY (Anatomy) - Abstract
Background TNF-α has been postulated to be a critical mediator contributing to airway inflammation. The purpose of this study was to evaluate the role of TNF-α in the induction of Th17 and Th2 cells related to asthma pathogenesis. Objective To evaluate detailed mechanisms for the modulation of IL-23 by TNF-α in sensitization period. Methods During sensitization period, 10 μg of rat anti-mouse TNF-α mAb was intravenously administrated one hour before the application of OVA and 0.1 μg of LPS. To see the relation between TNF-α and associated effectors cytokine, we replenished TNF-α KO mice with IL-23 during sensitization period. To assess cellular resources, CD11c+ cells isolated from lung tissue after sensitization were treated with anti-TNF-α Ab. Results Treatment of anti-TNF-α mAb during sensitization period significantly reduced airway eosinophilia, serum OVA-specific IgE levels and methacholine AHR compared to isotype Ab. Anti-TNF-α mAb treated mice showed significant reduction in the levels of IL-23 after sensitization in bronchoalveolar lavage fluid (BALF) as well as IL-17A, IL-4 levels in BALF after challenge compared with isotype Ab treated mice. Supplementation of IL-23 in TNF-α KO mice resulted in complete restoration of eosinophilic airway inflammation, AHR, and IL-17A and IL-4 expression in CD4+ T cells. Anti-TNF-α mAb treatment after sensitization significantly diminished the population of IL-23p19-secreting CD11c+ cells in lung. Conclusion TNF-α plays an important role in the development of airway inflammation by enhancing IL-23/Th17 and Th2 immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
37. The HLA- A*2402/ Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population.
- Author
-
Moon, Jangsup, Park, Han‐Ki, Chu, Kon, Sunwoo, Jun‐Sang, Byun, Jung‐Ick, Lim, Jung‐Ah, Kim, Tae‐Joon, Shin, Jung‐Won, Lee, Soon‐Tae, Jung, Keun‐Hwa, Jung, Ki‐Young, Jeon, Daejong, Kim, Dong Wook, Yu, Kyung‐Sang, Jang, In‐Jin, Kang, Hye‐Ryun, Park, Heung‐Woo, and Lee, Sang Kun
- Subjects
- *
HLA histocompatibility antigens , *LAMOTRIGINE , *CARBAMAZEPINE , *STEVENS-Johnson Syndrome , *DRUG side effects , *KOREANS , *DIAGNOSIS , *THERAPEUTICS , *DISEASES - Abstract
The use of lamotrigine ( LTG) can be limited by the occurrence of cutaneous adverse drug reactions (c ADRs) that range from maculopapular eruption ( MPE) to the more severe Stevens-Johnson syndrome and toxic epidermal necrolysis. A few human leukocyte antigen ( HLA)-related genetic risk factors for carbamazepine-induced cADR have been identified. However, the HLA-related genetic risk factors associated with LTG-induced cADR are not yet well known. We performed HLA genotyping in 50 Korean patients with epilepsy, including 21 patients presenting LTG-induced MPE and 29 LTG-tolerant patients. A significant association between the HLA-A*2402 allele and LTG-induced MPE was identified, in comparison with the LTG-tolerant group (odds ratio [ OR] 4.09, p = 0.025) and the general Korean population ( OR 3.949, p = 0.005). The frequencies of the Cw*0102 or Cw*0702 alleles were significantly higher in the LTG- MPE group than in the Korean population, whereas the frequency of the A*3303 allele was lower. The coexistence of the A*2402 and Cw*0102 alleles was significantly associated with the LTG- MPE group when compared to the LTG-tolerant group ( OR 7.88, p = 0.007). In addition, the Cw*0701 allele was more frequent in the LTG-tolerant group than in the Korean population. These findings suggest the presence of HLA-related genetic risk factors for LTG-induced MPE in the Korean population. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
38. Thalidomide Inhibits Alternative Activation of Macrophages In Vivo and In Vitro: A Potential Mechanism of Anti-Asthmatic Effect of Thalidomide.
- Author
-
Lee, Hyun Seung, Kwon, Hyouk-Soo, Park, Da-Eun, Woo, Yeon Duk, Kim, Hye Young, Kim, Hang-Rae, Cho, Sang-Heon, Min, Kyung-Up, Kang, Hye-Ryun, and Chang, Yoon-Seok
- Subjects
- *
THALIDOMIDE , *MACROPHAGES , *ANTIASTHMATIC agents , *IMMUNOLOGICAL adjuvants , *INFLAMMATION , *OVALBUMINS - Abstract
Background: Thalidomide is known to have anti-inflammatory and immunomodulatory actions. However, the effect and the anti-asthmatic mechanism of thalidomide in the pathogenesis of asthmatic airways are not fully understood. Objective: This study is designed to determine the effect and the potential mechanism of thalidomide in the pathogenesis of asthmatic airways using animal model of allergic asthma. Methods: Six-week-old female BALB/C mice were sensitized with alum plus ovalbumin (OVA) and were exposed to OVA via intranasal route for 3 days for challenge. Thalidomide 200 mg/kg was given via gavage twice a day from a day before the challenge and airway hyperresponsivenss (AHR), airway inflammatory cells, and cytokines in bronchoalveolar lavage fluids (BALF) were evaluated. The expression levels of pro-inflammatory cytokines and other mediators were evaluated using ELISA, real time (RT)-qPCR, and flow cytometry. CRL-2456, alveolar macrophage cell line, was used to test the direct effect of thalidomide on the activation of macrophages in vitro. Results: The mice with thalidomide treatment showed significantly reduced levels of allergen-induced BALF and lung inflammation, AHR, and the expression of a number of pro-inflammatory cytokines and mediators including Th2 related, IL-17 cytokines, and altered levels of allergen-specific IgG1/IgG2a. Of interesting note, thalidomide treatment significantly reduced expression levels of allergen- or Th2 cytokine-stimulated alternative activation of macrophages in vivo and in vitro. Conclusion: These studies highlight a potential use of thalidomide in the treatment of allergic diseases including asthma. This study further identified a novel inhibitory effect of thalidomide on alternative activation of macrophages as a potential mechanism of anti-asthmatic effect of thalidomide. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
39. Chronic Low Dose Chlorine Exposure Aggravates Allergic Inflammation and Airway Hyperresponsiveness and Activates Inflammasome Pathway.
- Author
-
Kim, Sae-Hoon, Park, Da-Eun, Lee, Hyun-Seung, Kang, Hye-Ryun, and Cho, Sang-Heon
- Subjects
- *
PHYSIOLOGICAL effects of chlorine , *INFLAMMATION , *ASTHMA , *AIRWAY (Anatomy) , *ALLERGIES , *EPIDEMIOLOGY , *BRONCHOALVEOLAR lavage , *DISEASES - Abstract
Background: Epidemiologic clinical studies suggested that chronic exposure to chlorine products is associated with development of asthma and aggravation of asthmatic symptoms. However, its underlying mechanism was not clearly understood. Studies were undertaken to define the effects and mechanisms of chronic low-dose chlorine exposure in the pathogenesis of airway inflammation and airway hyperresponsiveness (AHR). Methods: Six week-old female BALB/c mice were sensitized and challenged with OVA in the presence and absence of chronic low dose chlorine exposure of naturally vaporized gas of 5% sodium hypochlorite solution. Airway inflammation and AHR were evaluated by bronchoalveolar lavage (BAL) cell recovery and non-invasive phlethysmography, respectively. Real-time qPCR, Western blot assay, and ELISA were used to evaluate the mRNA and protein expressions of cytokines and other inflammatory mediators. Human A549 and murine epithelial (A549 and MLE12) and macrophage (AMJ2-C11) cells were used to define the responses to low dose chlorine exposure in vitro. Results: Chronic low dose chlorine exposure significantly augmented airway inflammation and AHR in OVA-sensitized and challenged mice. The expression of Th2 cytokines IL-4 and IL-5 and proinflammatory cytokine IL-1β and IL-33 were significantly increased in OVA/Cl group compared with OVA group. The chlorine exposure also activates the major molecules associated with inflammasome pathway in the macrophages with increased expression of epithelial alarmins IL-33 and TSLP in vitro. Conclusion: Chronic low dose exposure of chlorine aggravates allergic Th2 inflammation and AHR potentially through activation of inflammasome danger signaling pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
40. Anaphylaxis to Iodinated Contrast Media: Clinical Characteristics Related with Development of Anaphylactic Shock.
- Author
-
Kim, Min-Hye, Lee, Suh-Young, Lee, Seung-Eun, Yang, Min-Suk, Jung, Jae-Woo, Park, Chang Min, Lee, Whal, Cho, Sang-Heon, and Kang, Hye-Ryun
- Subjects
- *
ANAPHYLAXIS , *CONTRAST media , *IODINATION , *HYPOTENSION , *COMPARATIVE studies , *MEDICAL radiology - Abstract
Objective: Anaphylaxis is the most severe form of radiocontrast media (RCM) induced hypersensitivity and can be life-threatening if profound hypotension is combined. With increased use of iodine based RCM, related hypersensitivity is rapidly growing. However, the clinical characteristics and risk factors of RCM induced anaphylaxis accompanied by hypotension (anaphylactic shock) are not clearly defined. This study was performed to investigate the risk factors of RCM induced anaphylactic shock and the clinical value of RCM skin testing to identify causative agents in affected patients. Methods: We analyzed the data of RCM induced anaphylaxis monitored by an inhospital pharmacovigilance center at a tertiary teaching hospital from January 2005 to December 2012 and compared the clinical features and skin test results according to the accompanying hypotension. Results: Among total of 104 cases of RCM induced anaphylaxis, 34.6% of patients, developed anaphylaxis on their first exposure to RCM. Anaphylactic patients presenting with shock were older (57.4 vs. 50.1 years, p = 0.026) and had a history of more frequently exposure to RCM (5.1±7.8 vs. 1.9±3.3, p = 0.004) compared to those without hypotension. Among RCMs, hypotension was more frequent in anaphylaxis related to iopromide compared to other agents (85.0% vs. 61.4%, p = 0.011). Skin tests were performed in 51 patients after development of RCM induced anaphylaxis. Overall skin test positivity to RCM was 64.7% and 81.8% in patients with anaphylactic shock. Conclusion: RCM induced anaphylactic shock is related to multiple exposures to RCM and most patients showed skin test positivity to RCM. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
41. Anti-Asthmatic Activities of an Ethanol Extract of Aster yomena in an Ovalbumin-Induced Murine Asthma Model.
- Author
-
Sim, Ji Hyun, Lee, Hyun Seung, Lee, Sunkyung, Park, Dae Eun, Oh, Keunhee, Hwang, Kyung-A, Kang, Hye-Ryun, Ye, Sang-Kyu, and Kim, Hang-Rae
- Subjects
- *
ASTHMA prevention , *ENZYME metabolism , *LUNG analysis , *ALTERNATIVE medicine , *ANIMAL experimentation , *BIOPHYSICS , *BRONCHOALVEOLAR lavage , *CYTOKINES , *EOSINOPHILS , *HISTOLOGICAL techniques , *IMMUNOGLOBULINS , *RESEARCH methodology , *MEDICINAL plants , *MICE , *PLANT extracts , *STATISTICAL significance , *DESCRIPTIVE statistics - Abstract
Aster yomena is used in traditional remedies to treat cough, asthma and insect bites; however, its therapeutic mechanism is not completely understood. To elucidate the anti-asthmatic effect of A. yomena, we investigated the anti-asthmatic characteristics of an alcohol extract of A. yomena in an ovalbumin (OVA)-induced murine asthma model. In this study, we showed that A. yomena extract inhibited the overall pathophysiological features of asthma by suppressing Th2 responses and enzymes associated with the production of inflammatory mediators. This suppression resulted in decreased Th2 type cytokines and eosinophils in the bronchoalveolar lavage fluid and OVA-specific IgE in serum. Additionally, A. yomena extract significantly decreased airway hyperresponsiveness and abrogated the histopathological changes in the lungs, which reached normal levels in the OVA-challenged mice treated with A. yomena extract. These findings suggest that A. yomena could be a promising natural agent for treating bronchial asthma in humans. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
42. What Makes a Difference in Exercise-Induced Bronchoconstriction: An 8 Year Retrospective Analysis.
- Author
-
Park, Han-Ki, Jung, Jae-Woo, Cho, Sang-Heon, Min, Kyung-Up, and Kang, Hye-Ryun
- Subjects
- *
ASTHMA diagnosis , *BRONCHOCONSTRICTION , *EXERCISE physiology , *RETROSPECTIVE studies , *SYMPTOMS , *RESPIRATORY diseases , *METHACHOLINE chloride , *PROVOCATION tests (Medicine) - Abstract
Background: Exercise-induced bronchoconstriction (EIB) was recently classified into EIB alone and EIB with asthma, based on the presence of concurrent asthma. Objective: Differences between EIB alone and EIB with asthma have not been fully described. Methods: We retrospectively reviewed who visited an allergy clinic for respiratory symptoms after exercise and underwent exercise bronchial provocation testing. More than a 15% decrease of forced expiratory volume in 1 second (FEV1) from baseline to the end of a 6 min free-running challenge test was interpreted as positive EIB. Results: EIB was observed in 66.9% of the study subjects (89/133). EIB-positive subjects showed higher positivity to methacholine provocation testing (61.4% vs. 18.9%, p<0.001) compared with EIB-negative subjects. In addition, sputum eosinophilia was more frequently observed in EIB-positive subjects than in EIB-negative subjects (56% vs. 23.5%, p = 0.037). The temperature and relative humidity on exercise test day were significantly related with the EIB-positive rate. Positive EIB status was correlated with both temperature (p = 0.001) and relative humidity (p = 0.038) in the methacholine-negative EIB group while such a correlation was not observed in the methacholine-positive EIB group. In the methacholine-positive EIB group the time to reach a 15% decrease in FEV1 during exercise was significantly shorter than that in the methacholine-negative EIB group (3.2±0.7 min vs. 8.6±1.6 min, p = 0.004). Conclusions: EIB alone may be a distinct clinical entity from EIB with asthma. Conditions such as temperature and humidity should be considered when performing exercise tests, especially in subjects with EIB alone. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
43. Clinical Features and Prognostic Factors in Severe Cutaneous Drug Reactions.
- Author
-
Yang, Min-Suk, Kang, Min-Gyu, Jung, Jae-Woo, Song, Woo-Jung, Kang, Hye-Ryun, Cho, Sang-Heon, and Min, Kyung-Up
- Subjects
- *
DRUG side effects , *STEVENS-Johnson Syndrome , *TOXIC epidermal necrolysis , *BIOMARKERS , *PHENOTYPES , *HOSPITAL care , *PHYSIOLOGICAL effects of allopurinol - Abstract
Background: Severe cutaneous adverse reactions (SCARs) include Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS). SJS and TEN (SJS/TEN) and DRESS are thought to be different diseases; however, they share some clinical and laboratory features. Although SCORTEN serves as an excellent prognostic marker for SJS/TEN, there is still a need for development of other prognostic markers for SCARs. Methods: The study population consisted of 88 SCAR patients. Clinical characteristics and clinical manifestations were compared between SJS/TEN and DRESS. Risk factor analyses for prolonged hospitalization were performed. Results: Of the 88 patients, 41 were SJS/TEN and 47 were DRESS. Mortality rates of TEN and DRESS were 9.8 and 2.1%, respectively. Allopurinol and carbamazepine were the most common causes of both SJS/TEN and DRESS (34.7 and 62.9%, respectively). Some of the systemic presentations, such as fever and laboratory abnormalities were common in both phenotypes. Thrombocytopenia tended to be related to prolonged hospitalization (longer than 3 weeks) in SJS/TEN (odds ratio, OR = 5.1, 95% confidence interval, CI 0.8-31.8, p = 0.076). In DRESS patients, leukocytosis at presentation (OR 4.8, 95% CI 1.1-20.3, p = 0.03) was related to prolonged hospitalization. Conclusions: Clinical features of SCARs in a tertiary hospital in Korea were similar to those reported previously. SJS/TEN and DRESS shared some clinical and laboratory features. Thrombocytopenia for SJS/TEN and leukocytosis at presentation for DRESS may be useful prognostic markers for prolonged hospitalization. © 2013 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
44. Incidence and risk factors of late adverse reactions to low-osmolar contrast media: A prospective observational study of 10,540 exposures.
- Author
-
Kang, Dong Yoon, Lee, Suh-Young, Ahn, Yoon Hae, Yoon, Soon Ho, Choi, Young Hoon, Lee, Whal, and Kang, Hye-Ryun
- Subjects
- *
CONTRAST media , *DRUG allergy , *DRUG side effects , *LONGITUDINAL method , *COMPUTED tomography , *DISEASE incidence , *OSMOLAR concentration - Abstract
Purpose: To evaluate the incidence and risk factors of late adverse reactions (ARs) to non-ionic low-osmolar contrast media (LOCM).Methods: The occurrence of late AR was monitored on day 1 and from day 7 to day 28 in all patients who received enhanced computed tomography using LOCM during a 5-week study period in a single tertiary hospital. Patients who experienced late AR were followed up for three years.Results: Among the total 10,540 LOCM exposures, 315 ARs (3.0%) were reported; acute ARs occurred in 108 LOCM exposures (1.0%) and late ARs occurred in 207 LOCM exposures (2.0%) (90.9% within one week, 9.1% developed afterwards by day 20). Previous history of drug allergy (odds ratio [OR] = 4.59; 95% confidence interval [CI] 2.17-9.71) and allergic diseases (OR = 2.54; 95% CI 1.32-4.91) were risk factors of late ARs to LOCM. Although the recurrence rate was lowered with premedication from 8.5% to 1.7% (8/94 vs. 3/178; p = 0.016), LOCM change did not make difference compared to reuse of the culprit LOCM (2/38 vs. 9/234; p = 0.655). In patients with a history of late AR to LOCM, the risk of recurrent reactions decreased with longer time intervals between exposures (OR = 0.86; 95% CI: 0.77-0.97; p = 0.025) and with the use of antihistamine premedication (OR = 0.27; 95% CI: 0.06-0.99; p = 0.049).Conclusions: Late ARs to LOCM occurred mostly within one week. The use of premedication may be helpful in reducing the recurrence of late ARs. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
45. Economic Costs for Adult Asthmatics According to Severity and Control Status in Korean Tertiary Hospitals.
- Author
-
Kim, Sae-Hoon, Kim, Tae-Wan, Kwon, Jae-Woo, Kang, Hye-Ryun, Lee, Yong-Won, Kim, Tae-Bum, Kim, Sang-Heon, Park, Heung-Woo, Park, Sung-Woo, Chang, Yoon-Seok, Cho, You-Sook, Park, Jung-Won, Cho, Young-Joo, Yoon, Ho-Joo, Cho, Sang-Heon, Choi, Byoung-Whui, Moon, Hee-Bom, and Min, Kyung-Up
- Subjects
- *
ASTHMATICS , *MEDICAL care costs , *KOREANS , *DISEASE prevalence , *ASTHMA treatment , *SOCIOECONOMIC factors , *MULTIVARIATE analysis , *DISEASES - Abstract
Objective. The prevalence of asthma is increasing, and asthma causes considerable socioeconomic burden worldwide. Few studies have been conducted to evaluate the risk factors associated with economic cost of asthma in Korea. This study evaluated asthma cost according to severity, control, and patient factors in Korean tertiary hospitals. Methods. Direct and indirect costs were assessed in physician-diagnosed adult asthmatics recruited from eight tertiary hospitals in Korea. Official direct medical costs were derived from the analysis of 1-year expenditures related to hospital care utilization and asthma medication. Nonofficial medical costs, nonmedical direct costs, and indirect costs were investigated using a questionnaire designed specifically for the study. Results. A total of 314 patients with persistent asthma were recruited. Both direct and indirect costs were significantly higher for patients with severe persistent asthma than for those with mild and moderate persistent asthma ($2214 vs. $871 and $978, p < .001; $2927 vs. $490 and $443, p < .001, respectively). Costs of asthma increased significantly in poorly controlled compared with somewhat controlled and well-controlled asthma ($7009.8 vs. $2725.3 vs. $1517.3, respectively; p < .001). After stratification for severity, a significant cost increase in the poorly controlled asthma group was observed only for indirect costs and not for direct costs. A multivariate analysis showed that female gender was a risk factor for increased indirect costs. Conclusion. The burden of asthma was higher both for patients with severe persistent asthma and for patients with poorly controlled asthma. More effective strategies are needed to improve control status, particularly targeting patients with severe asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
46. HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency.
- Author
-
Jung, Jae-Woo, Song, Woo-Jung, Kim, Yon-Su, Joo, Kwon Wook, Lee, Kyung Wha, Kim, Sae-Hoon, Park, Heung-Woo, Chang, Yoon-Seok, Cho, Sang-Heon, Min, Kyung-Up, and Kang, Hye-Ryun
- Subjects
- *
CHRONIC kidney failure , *HLA histocompatibility antigens , *HYPERURICEMIA , *DRUG administration , *RETROSPECTIVE studies , *KIDNEY transplantation , *ALLERGIES , *PURINES , *THERAPEUTICS - Abstract
Background. Although allopurinol is a very effective urate-lowering drug for complicated hyperuricemia, in some patients, it can induce severe cutaneous adverse reactions (SCARs). Recent investigations suggest that HLA-B*5801 is a very strong marker for allopurinol-induced SCARs, especially in the population with a high frequency of HLA-B*5801. Korea is one of the countries with a high frequency of HLA-B*5801 which is the only subtype of HLA-B58 in the Korean population.Objective. This study was conducted to find out the incidence of allopurinol-induced hypersensitivity on patients with chronic renal insufficiency (CRI) according to HLA-B58 and the clinical implications of HLA-B58 as a risk marker for the development of allopurinol-induced hypersensitivity.Methods. We retrospectively reviewed the medical records of patients with CRI who took allopurinol and carried out serologic human leukocyte antigen (HLA) typing for kidney transplantation between January 2003 and May 2010.Results. Among a total of 448 patients with CRI, 16 (3.6%) patients experienced allopurinol hypersensitivity. Nine of these patients (2.0%) were diagnosed with SCARs (two Stevens–Johnson syndrome and seven allopurinol hypersensitivity syndrome) and seven patients (1.6%) had simple maculopapular rashes. The HLA-B58 allele was present in all patients with allopurinol-induced SCARs, while the frequency of HLA-B58 was only 9.5% in allopurinol-tolerant patients (P < 0.05). The incidence of allopurinol-induced SCARs in CRI shows a wide disparity according to HLA-B58 [18% in HLA-B58 (+) versus 0% in HLA-B58 (−)]. Among patients without HLA-B58, most (98.2%) of the CRI patients were tolerant to allopurinol and only 1.8% experienced simple rashes after taking allopurinol.Conclusions. In this study, the incidence of allopurinol-induced SCARs was considerably high in CRI patients with HLA-B58. This finding indicates that the presence of HLA-B58 may increase the risk of allopurinol-induced SCARs. Screening tests for HLA-B58 in CRI patients will be clinically helpful in preventing severe allopurinol hypersensitivity reactions. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
47. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- Author
-
Kim, Sae-Hoon, Lee, Kyung Wha, Song, Woo-Jung, Kim, Sang-Heon, Jee, Young-Koo, Lee, Sang-Min, Kang, Hye-Ryun, Park, Heung-Woo, Cho, Sang-Heon, Park, Seong-Ho, Min, Kyung-Up, and Chang, Yoon-Seok
- Subjects
- *
CARBAMAZEPINE , *HLA histocompatibility antigens , *DRUG side effects , *CLINICAL drug trials , *PHARMACOGENOMICS , *KOREANS - Abstract
Summary: Background: Although the US FDA recommends screening for HLA-B*1502 allele in most of Asian ancestry before initiating carbamazepine therapy, the HLA associations with carbamazepine hypersensitivity in non-Chinese Asian populations remain unclear. This study investigated the association between the HLA class I genotype and carbamazepine-induced severe cutaneous adverse reaction (SCAR) in Koreans. Methods: Twenty-four patients who had developed carbamazepine-induced SCAR (7 Stevens–Johnson syndrome (SJS), 17 drug hypersensitivity syndrome (HSS)), 50 carbamazepine-tolerant controls from the Korean Pharmacogenetic Adverse Drug Reaction Research Network and data of 485 Korean general population from a previously published study were recruited. HLA-A, -B, and -C genotyping was performed by direct DNA sequence analysis. Results: Only one of the seven SJS patients was positive for the B*1502 allele, but the frequency of B*1511 was much higher in the patients with CBZ-SJS than in the CBZ-tolerant control patients (P =0.011, P c =not significant; OR=18.0(2.3–141.2)). The frequencies of A*3101 in carbamazepine-induced HSS and SCAR were significantly higher than those in carbamazepine-tolerant controls (P c =0.011, OR=8.8(2.5–30.7) and P c =0.013, OR=7.3(2.3–22.5), respectively). The frequencies of B*1511 in carbamazepine-SJS and A*3101 in carbamazepine-HSS/SCAR were significantly higher than those in the general population. Conclusions: HLA-B*1502 does not seem to be an effective predictive marker for carbamazepine-induced SCAR, while HLA-B*1511 and A*3101 was associated with carbamazepine-induced SJS and HSS/SCAR respectively in the Korean population. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
48. Outcomes of premedication for non-ionic radio-contrast media hypersensitivity reactions in Korea
- Author
-
Kim, Sae-Hoon, Lee, So-Hee, Lee, Sang-Min, Kang, Hye-Ryun, Park, Heung-Woo, Kim, Sun-Sin, Cho, Sang-Heon, Min, Kyung-Up, Kim, You-Young, and Chang, Yoon-Seok
- Subjects
- *
DRUG allergy , *NONIONIC contrast media , *ANAPHYLAXIS , *PREANESTHETIC medication , *ADRENOCORTICAL hormones , *HEALTH outcome assessment - Abstract
Abstract: Background: Radio-contrast media (CM)-related adverse reactions are important clinical problems that may cause fatal anaphylaxis. Accordingly, it has been common practice to premedicate patients who have had previous reactions to CM with corticosteroids, antihistamines, and H2 blockers to prevent hypersensitive reactions. However, the effectiveness of premedication has not been properly demonstrated, especially in cases related to non-ionic CM. In this study, we evaluated the effectiveness of premedication at preventing of non-ionic CM immediate-type hypersensitivity reactions. Methods: A total of 30 patients who had been pretreated with corticosteroid and H1 antihistamines and/or H2 blockers in a 3-year period were enrolled. The results of premedication were evaluated in terms of clinical characteristics and the features of breakthrough reactions. Results: Hypersensitivity reactions were not prevented in 5 of the 30 patients who had experienced prior CM reactions (overall recurrence rate after premedication 16.7%; 4/17 patients with mild previous reactions, and 1/13 patients with severe previous reactions). The recurrence rate after premedication was significantly higher in patients with mild previous reactions than in those with severe reactions (23.5% vs. 7.7%; p <0.001). The breakthrough reactions were similar to the prior reactions in terms of severity and clinical manifestations. Conclusion: Premedication with corticosteroid and H1 antihistamines and/or H2 blockers effectively prevent non-ionic CM-related adverse events in most patients who have had severe previous reactions to CM. However, physicians should be aware of the possibility of premedication failing and of breakthrough reactions, even in cases in which the previous reactions were mild. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
49. Correction to: Immediate and delayed hypersensitivity after intra-arterial injection of iodinated contrast media: a prospective study in patients with coronary angiography.
- Author
-
Sohn, Kyoung-Hee, Kim, Gun-Woo, Lee, Suh-Young, Kim, Hyo-Soo, Cho, Sang-Heon, Han, Jung-Kyu, and Kang, Hye-Ryun
- Subjects
- *
DELAYED hypersensitivity , *ALLERGIES , *CORONARY angiography , *CONTRAST media , *INTRA-arterial injections - Abstract
The original version of this article, published on 01 April 2019, unfortunately contained a mistake. The presentation of Fig. 1 was incorrect. The corrected figure is given below. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
50. Corticosteroid prophylaxis may be not required for patients with mild hypersensitivity reaction to low-osmolar contrast media.
- Author
-
Park, Sae-Jin, Lee, Suh-Young, Yoon, Soon-Ho, Choi, Young-Hun, and Kang, Hye-Ryun
- Subjects
- *
CONTRAST media , *ALLERGIES , *PREVENTIVE medicine - Published
- 2020
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resourcesDiscovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.